Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS).
暂无分享,去创建一个
L. Kiesel | E. Nieschlag | J. Gromoll | R. Greb | M. Zitzmann | A. Schüring | B. Sonntag | A. Welp
[1] A. Tsatsoulis,et al. Review: Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess — Evidence from Experimental, Clinical and Genetic Association Studies , 2014 .
[2] L. Haeberle,et al. The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[3] S. Moon,et al. Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. , 2008, Fertility and sterility.
[4] M. P. Perme,et al. Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome. , 2008, Fertility and sterility.
[5] G. Ning,et al. Androgen receptor gene CAGn trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome , 2008, Endocrine.
[6] K. Taylor,et al. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[7] A. Tsatsoulis,et al. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. , 2008, Human reproduction.
[8] D. Deforce,et al. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[9] T. Maltaris,et al. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[10] M. McCarthy,et al. Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome , 2007, Clinical endocrinology.
[11] D. Dewailly,et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.
[12] A. Pfeiffer,et al. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. , 2006, European journal of endocrinology.
[13] A. Tsatsoulis,et al. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. , 2006, The Journal of clinical endocrinology and metabolism.
[14] M. Beckmann,et al. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[15] R. Azziz. Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature , 2006 .
[16] M. Urbanek,et al. Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. , 2005, The Journal of clinical endocrinology and metabolism.
[17] A. Pinchera,et al. Androgen receptor polymorphism (CAG repeats) and androgenicity , 2005, Clinical endocrinology.
[18] D. Abbott,et al. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? , 2005, Human reproduction update.
[19] R. Voutilainen,et al. Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. , 2005, Fertility and sterility.
[20] J. L. San Millán,et al. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.
[21] V. Burke,et al. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management , 2005, Clinical endocrinology.
[22] E. Nieschlag,et al. X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. , 2004, The Journal of clinical endocrinology and metabolism.
[23] D. Ehrmann. Polycystic ovary syndrome. , 2004, The New England journal of medicine.
[24] Ricardo Azziz,et al. 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .
[25] D. Dewailly,et al. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. , 2004, Human reproduction update.
[26] K. Taylor,et al. Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.
[27] Didier Dewailly,et al. Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.
[28] Jarmo Jääskeläinen,et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. , 2003, The Journal of clinical endocrinology and metabolism.
[29] R. Junker,et al. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males , 2001, Clinical endocrinology.
[30] M. McCarthy,et al. Candidate genes in polycystic ovary syndrome. , 2001, Human reproduction update.
[31] P. Björntorp,et al. Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor  Gene Are Associated with Androgen Levels in Women* , 2022 .
[32] E. Yong,et al. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. , 2000, The Journal of clinical endocrinology and metabolism.
[33] J. L. San Millán,et al. The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. , 2000, The Journal of clinical endocrinology and metabolism.
[34] H. Mason. Function of the polycystic ovary , 2000, Human fertility.
[35] G. Chrousos,et al. Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. , 1999, The Journal of clinical endocrinology and metabolism.
[36] C. Bondy,et al. Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.
[37] A. Dunaif,et al. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.
[38] S. Hillier,et al. Role of androgens in follicle maturation and atresia. , 1997, Bailliere's clinical obstetrics and gynaecology.
[39] M. Leppert,et al. Heritability of X chromosome--inactivation phenotype in a large family. , 1996, American journal of human genetics.
[40] S. Franks,et al. Polycystic ovary syndrome. , 1995, Archives of disease in childhood.
[41] S. Franks,et al. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.
[42] N. Chamberlain,et al. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. , 1994, Nucleic acids research.
[43] R. Legro,et al. Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics , 1994, Obstetrics and gynecology.
[44] L. Jin,et al. Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. , 1992, Genomics.
[45] S. Franks,et al. Polycystic Ovaries A Common Finding in Normal Women , 1988 .
[46] J. Wadsworth,et al. POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.
[47] Chawnshang Chang,et al. Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.
[48] J. Price,et al. MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.
[49] D. Ferriman,et al. Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.
[50] M. Rizzo,et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.
[51] B. Fauser,et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.
[52] T. Hickey,et al. The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.
[53] F. Bischoff,et al. Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. , 2001, American journal of medical genetics.
[54] M. Lyon,et al. Some milestones in the history of X-chromosome inactivation. , 1992, Annual review of genetics.
[55] H. Zoghbi,et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.